Breaking News on Global Pharmaceutical Technology & Manufacturing

Tabletting, coating & ancillary equipment

News headlines

Roche Spanish plant becomes eighth solid dose site for Recipharm

20-Sep-2017 - Recipharm has acquired a Spanish manufacturing plant and signed a supply deal with former owner Roche for a range of solid dose products worth €35m a year.

Puracap's Wuhan site passes US FDA inspection prompted by ANDA

19-Sep-2017 - US regulators are satisfied a soft gelatin capsule plant in Wuhan, China is up to code according to Puracap Pharmaceutical LLC.

Recipharm to make clinical trial cancer candidate for Kancera

18-Sep-2017 - Recipharm will make clinical trial capsules to support oncology candidate KAND567, a former AstraZeneca Fractalkine receptor inhibitor being developed by Kancera.


Single shot in 'tiny coffee cups’ could deliver multiple vaccines, MIT

18-Sep-2017 - 3-D microparticles which degrade at differing rates in the body could allow multiple doses of drugs or vaccines to be administered in a single injection, say MIT researchers.

BMS inks $105m deal to access Halozyme drug delivery tech

14-Sep-2017 - Bristol-Myers Squibb will also make up to $160m in milestone payments for each candidate developed using Halozyme Therapeutics’ large-volume biologics delivery platform.

No fraud, no conspiracy, no error: France and Merck say reformulated Euthyrox is safe

12-Sep-2017 - A new formulation of Euthyrox linked to a surge in adverse event reports in France is safe, effective and more consistent than the older version of the drug say ANSM and Merck.

Oramed looking for commercialisation partner for oral insulin in US

06-Sep-2017 - Oramed is eying up commercial partnerships for its oral insulin candidate following a positive meeting with the US FDA to discuss an appropriate approval pathway.

Vial-up: Althea adds fill/finish capabilities in California

31-Aug-2017 - A vial filling line at Ajinomoto Althea’s manufacturing site in San Diego will maximise yield and reduce product loss, the CMO says.

Dissolution testing and dirty gaskets: US FDA warns Hetero Labs

30-Aug-2017 - The US FDA has sent a warning letter to Hetero Labs Limited citing GMP violations at its finished dose formulations facility in Telangana, India.

Catalent looking to parenteral dosage form capability for future expansion

29-Aug-2017 - Catalent says it will focus its M&A strategy to fill the injectables capability gap in its CDMO offering.

Micro-Sphere pumps $22m into capsule filling facility

23-Aug-2017 - Spray drying and capsule filling-focused Micro-Sphere is expanding manufacturing capabilities at its facility in Ticino, Switzerland.

Hikma upping injectables capacity by as much as 500% by end of 2017

22-Aug-2017 - Hikma has ramped up capacity at manufacturing facilities in the US and Portugal manufacturing to meet the growing demand for its lyophilised and oncology products.

German lyophilisation ramp-up could be delayed into next year, Recipharm

31-Jul-2017 - A lyophilisation expansion announced in 2013 at an aseptic facility in Wasserburg, Germany has been delayed due to lengthy approval processes, says Recipharm.

TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

21-Jul-2017 - TPI Enterprises has bought Vistin Pharma ASA’s opiates and tabletting division for A$25.4m ($201.m) in a deal designed to expand the firm beyond its narcotic raw materials business.

Idifarma adds contract capsule filling to offering

18-Jul-2017 - Idifarma has bolstered its capsule filling capabilities at its manufacturing plant in Pamplona, Spain.

Bayer ends methamphetamine abuse deterrent partnership with Acura

06-Jul-2017 - Bayer has pulled-out of a development and licensing deal for a pseudoephedrine containing product based on Acura Pharmaceuticals’ methamphetamine resistant technology, Impede.

Corning life science focus: '21st century glass for 21st century drugs'

21-Jun-2017 - Corning says it is on the brink of capturing an increased share of the $12bn glass quality and packaging markets through material advancements in the space.

Takeda inaugurates €100m German oral solid dose plant

20-Jun-2017 - Takeda has completed a €100m ($112m) oral solid dosage production facility in Germany.

'Talking' smart pill looks to overhaul prescription opioid space and stop abuse

08-Jun-2017 - Pop Test Abuse Deterrent Technologies has received a patent for an opioid drug delivery and abuse deterrent ‘smart pill’ it says can prevent death, theft, diversion and counterfeiting.

Vetter inks ‘pain-free’ needle deal to meet alternative drug delivery demand

05-Jun-2017 - Vetter Pharma has signed a strategic agreement to develop Microdermics’ microneedle drug delivery technology.

Related News

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation